Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 GWAS-based association between RWDD3 and TECTA variants and paclitaxel induced neuropathy could not be confirmed in Scandinavian ovarian cancer patients.

× No keyword cloud information.

16 in total

Review 1. Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview.

Authors: Alexandre Chan; Daniel L Hertz; Manuel Morales; Elizabeth J Adams; Sharon Gordon; Chia Jie Tan; Nathan P Staff; Jayesh Kamath; Jeong Oh; Shivani Shinde; Doreen Pon; Niharkia Dixit; James D'Olimpio; Cristina Dumitrescu; Margherita Gobbo; Kord Kober; Samantha Mayo; Linda Pang; Ishwaria Subbiah; Andreas S Beutler; Katherine B Peters; Charles Loprinzi; Maryam B Lustberg
Journal: Support Care Cancer Date: 2019-07-30 Impact factor: 3.603

Review 2. Chemotherapy-induced peripheral neuropathy: A current review.

Authors: Nathan P Staff; Anna Grisold; Wolfgang Grisold; Anthony J Windebank
Journal: Ann Neurol Date: 2017-06-05 Impact factor: 10.422

3. Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance).

Authors: Ganesh K Boora; Amit A Kulkarni; Rahul Kanwar; Peter Beyerlein; Rui Qin; Michaela S Banck; Kathryn J Ruddy; Josef Pleticha; Cynthia A Lynch; Robert J Behrens; Stephan Züchner; Charles L Loprinzi; Andreas S Beutler
Journal: J Neurol Sci Date: 2015-06-27 Impact factor: 3.181

Review 4. Genomic architecture of pharmacological efficacy and adverse events.

Authors: Aparna Chhibber; Deanna L Kroetz; Kelan G Tantisira; Michael McGeachie; Cheng Cheng; Robert Plenge; Eli Stahl; Wolfgang Sadee; Marylyn D Ritchie; Sarah A Pendergrass
Journal: Pharmacogenomics Date: 2014-12 Impact factor: 2.533

5. RWDD3 and TECTA variants not linked to paclitaxel induced peripheral neuropathy in North American trial Alliance N08C1.

Authors: Amit A Kulkarni; Ganesh Boora; Rahul Kanwar; Kathryn J Ruddy; Michaela S Banck; Nguyet Le-Lindqwister; Terry M Therneau; Charles L Loprinzi; Andreas S Beutler
Journal: Acta Oncol Date: 2014-12-31 Impact factor: 4.089

6. RSUME inhibits VHL and regulates its tumor suppressor function.

Authors: J Gerez; L Tedesco; J J Bonfiglio; M Fuertes; M Barontini; S Silberstein; Y Wu; U Renner; M Páez-Pereda; F Holsboer; G K Stalla; E Arzt
Journal: Oncogene Date: 2014-12-15 Impact factor: 9.867

Review 7. Pathogenesis of paclitaxel-induced peripheral neuropathy: A current review of in vitro and in vivo findings using rodent and human model systems.

Authors: Nathan P Staff; Jill C Fehrenbacher; Martial Caillaud; M Imad Damaj; Rosalind A Segal; Sandra Rieger
Journal: Exp Neurol Date: 2019-11-21 Impact factor: 5.330

8. CYP3A4*22 genotype and systemic exposure affect paclitaxel-induced neurotoxicity.

Authors: Anne-Joy M de Graan; Laure Elens; Jason A Sprowl; Alex Sparreboom; Lena E Friberg; Bronno van der Holt; Pleun J de Raaf; Peter de Bruijn; Frederike K Engels; Ferry A L M Eskens; Erik A C Wiemer; Jaap Verweij; Ron H J Mathijssen; Ron H N van Schaik
Journal: Clin Cancer Res Date: 2013-05-02 Impact factor: 12.531

9. Informative gene network for chemotherapy-induced peripheral neuropathy.

Authors: Cielito C Reyes-Gibby; Jian Wang; Sai-Ching J Yeung; Sanjay Shete
Journal: BioData Min Date: 2015-08-12 Impact factor: 2.522

10. Solute Carrier Transportome in Chemotherapy-Induced Adverse Drug Reactions.

Authors: Jason T Anderson; Kevin M Huang; Maryam B Lustberg; Alex Sparreboom; Shuiying Hu
Journal: Rev Physiol Biochem Pharmacol Date: 2022 Impact factor: 7.500